Company attributes
Industry
B2X
CEO
Founder
Pitchbook URL
Legal Name
REGENXBIO Inc.0
Legal classification
Date Incorporated
2010
Number of Employees (Ranges)
201 – 500
Phone Number
+124055281810
Number of Employees
3
Full Address
9600 Blackwell Road Suite 210 Rockville, MD 20850 United States
9804 Medical Center Drive, Rockville, MD 20850, USA0
CIK Number
Investors
DUNS Number
080587024
Founded Date
2008
0Total Funding Amount (USD)
118,891,875
Latest Funding Round Date
May 2015
Stock Symbol
RGNX
Exchange
Latest Funding Type
Country
Other attributes
Company Operating Status
Active
Ticker Symbol
RGNX0
Wikidata ID
REGENXBIO is a biotechnology company focused on the development, commercialization and licensing of recombinant adeno‐associated virus (AAV) gene therapy. REGENXBIO's NAV® Technology Platform is a proprietary AAV gene delivery platform.
Timeline
No Timeline data yet.
